- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02150954
Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor
October 24, 2023 updated by: Duke University
A Randomized Comparison of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor
The purpose of this research study is to compare induction of labor using a foley catheter bulb with a low dose of oxytocin versus a foley catheter bulb with an increasing dose of oxytocin.
A foley catheter bulb with or without oxytocin is a common method of labor induction in patients whose cervix is not significantly dilated or thinned out (effaced).
Oxytocin (pitocin) is a medicine used to increase the number and strength of the womb's contractions.
Study Overview
Study Type
Interventional
Enrollment (Actual)
121
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with a singleton pregnancy
- Term pregnancy (> 37 weeks gestation)
- Age ≥ 18 years
- Bishop score < 5
- Contractions < 6/hr
- Reassuring fetal heart tracing
Exclusion Criteria:
- Rupture of membranes
- Antepartum bleeding
- Fetal death
- Placenta previa or low lying placenta
- Active genital herpes infection
- Previous use of an induction or preinduction agent during the current pregnancy
- EFW >4500 grams
- Non reassuring fetal testing
- Inability to pass foley through cervix
- Prior cesarean section
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: foley bulb induction with low dose pitocin
Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
|
Other Names:
|
|
Active Comparator: foley bulb with standard incremental pitocin infusion protocol
Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to the Second Stage of Labor
Time Frame: foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)
|
The second stage of labor was defined as the time from complete cervical dilation to delivery of the fetus.
|
foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)
|
|
Time to Delivery
Time Frame: foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)
|
Time from foley balloon placement until neonate delivery
|
foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Cesarean Delivery
Time Frame: during admission for delivery, up to approximately 4 days
|
Number of participants having a cesarean delivery
|
during admission for delivery, up to approximately 4 days
|
|
Time to Active Labor
Time Frame: during admission for delivery, up to approximately 4 days
|
Active labor was defined as the presence of regular, painful contractions and a minimum of 2 cm cervical dilation and complete effacement in nulliparous women or a minimum of 4 cm cervical dilation in multiparous women.
|
during admission for delivery, up to approximately 4 days
|
|
Time to Foley Expulsion or Removal
Time Frame: foley bulb placement until removal, up to 10 hours
|
Time from foley balloon placement until the expulsion or removal of the foley balloon.
|
foley bulb placement until removal, up to 10 hours
|
|
Incidence of Uterine Hyperstimulation
Time Frame: during admission for delivery, up to approximately 4 days
|
Uterine hyperstimulation (tachysystole) was defined as uterine contractions occurring greater than 12 in 20 minutes.
|
during admission for delivery, up to approximately 4 days
|
|
Neonatal Outcome: Birthweight
Time Frame: at time of birth (0 to 1 hour)
|
at time of birth (0 to 1 hour)
|
|
|
Neonatal Outcome: Placental Abruption
Time Frame: during admission for delivery, up to approximately 4 days
|
number of participants with placental abruption
|
during admission for delivery, up to approximately 4 days
|
|
Neonatal Outcome: Late Fetal Heart Rate Decelerations
Time Frame: during admission for delivery, up to approximately 4 days
|
Late fetal heart rate decelerations were defined as a gradual decrease in the fetal heart rate associated with uterine contraction with the nadir of the deceleration occurring after the peak of the contraction.
|
during admission for delivery, up to approximately 4 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chad Grotegut, MD, Duke University
- Principal Investigator: Brennan Fitzpatrick, MD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Actual)
March 1, 2009
Study Completion (Actual)
March 1, 2009
Study Registration Dates
First Submitted
May 23, 2014
First Submitted That Met QC Criteria
May 27, 2014
First Posted (Estimated)
May 30, 2014
Study Record Updates
Last Update Posted (Actual)
October 26, 2023
Last Update Submitted That Met QC Criteria
October 24, 2023
Last Verified
June 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00001312
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Induction of Labor
-
Aalto UniversityHelsinki University Central Hospital; Tampere University Hospital; Jyväskylä...Not yet recruitingInduction of Labor | Cervical Ripening | Cervical Ripening and Induction of LaborFinland
-
Aalto UniversityUniversity of Minnesota; University of Mississippi Medical CenterNot yet recruitingCervical Ripening | Induction of Birth | Balloon Catheter for Labor Induction | Cervical Ripening and Induction of Labor
-
Rambam Health Care CampusNot yet recruitingInduction of Labor
-
Ochsner Health SystemNorthwell HealthTerminatedInduction of LaborUnited States
-
Brigham and Women's HospitalCompleted
-
Aultman Health FoundationCompletedInduction of LaborUnited States
-
Dina Yahia MansourUnknown
-
HaEmek Medical Center, IsraelCompletedSingle Balloon Catheter Compared With Double Balloon Catheter for Ripening of the Unfavorable CervixInduction of LaborIsrael
-
Tel-Aviv Sourasky Medical CenterUnknown
-
University of Roma La SapienzaNot yet recruiting
Clinical Trials on pitocin
-
Universiti Kebangsaan Malaysia Medical CentreCompletedAnaesthesia | Pregnancy RelatedMalaysia
-
Rambam Health Care CampusRecruitingCesarean Delivery Affecting Fetus | Delivery ComplicationIsrael
-
Rambam Health Care CampusRecruitingChorioamnionitis | Cesarean Section Complications | Endometritis | Fetal InfectionIsrael
-
Samuel Lunenfeld Research Institute, Mount Sinai...CompletedObesity | Postpartum HemorrhageCanada
-
Milton S. Hershey Medical CenterWithdrawnBlood Loss Anemia | Uterine Atony With Hemorrhage
-
NYU Langone HealthWithdrawnPostpartum Hemorrhage | Uterine Atony
-
Wake Forest University Health SciencesWithdrawn
-
University of California, San DiegoCompleted
-
Samuel Lunenfeld Research Institute, Mount Sinai...CompletedPostpartum HemorrhageCanada
-
Samuel Lunenfeld Research Institute, Mount Sinai...CompletedPostpartum Hemorrhage | TwinCanada